A lab running in vivo metabolic studies would reconstitute this with bacteriostatic water, dose it at 5mg or 10mg depending on your batch, and monitor weight loss and glucose tolerance over a 4-week window—that's where the dual GIP/GLP-1 agonism actually shows its value. We typically have stock, but confirm lead time if you're ordering more than 50 units or so, as the 10-vial kits move fast.

It's white powder, 99% by HPLC, CAS number 2023788-19-2, and we ship it in sealed kits with COAs from the batch—usually takes 20 days or so for dilevery if you're outside Asia. The molecular weight is 4813 g/mol, which matters for reconstitution calculations, and the 5mg per vial format keeps handling straightforward for most research protocols.

Storage is 2-8°C, protected form light, and retest period is 24 months—but don't expect it to hold full potency if left at room temp for more than a week. What it does is bind both receptors simultaneously, which is tighter tolerance than most single-target GLP-1 agonists on the market.

We don't do MOQs under 10 kits for wholesale pricing, and payment is via T/T or L/C with standdard paperwork. Basically, if you're buying for a contract research org, teh COA and SDS are included with every shipment—no need to chase documents later.

One detail you might not think to ask: the powder is slightly hygroscopic, so open vials in low-humidity environment or you'll get clumping. It's not suited for oral dosing at all—this is strictly injection-grade for research, so don't try to reformulate it for that.